Clinical Trial Update: Study of the Safety and Efficacy of SU-011,248 in Adult Patients With Advanced Kidney Cancer [Phase 2]

View source ↗

Summary

Pfizer reports an update on the Phase 2 study of SU-011,248 in adults with advanced kidney cancer, focusing on safety and efficacy. The trial status is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer

Drugs mentioned

• SU-011,248

Snippet

Sponsor: Pfizer | Conditions: Kidney Neoplasms | Phase 2 | Status: COMPLETED